Received Dec 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 449J9 | — |
Penmenvy liquid portion only administration; Penmenvy liquid portion only administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received Men ABCWY NVS (Penmenvy) (batch number 449J9, expiry date 08-OCT-2026) for prophylaxis. In NOV-2025, the patient received Penmenvy. In NOV-2025, an unknown time after receiving Penmenvy, the patient experienced inappropriate dose of vaccine administered (Verbatim: Penmenvy liquid portion only administration) and inappropriate preparation of medication (Verbatim: Penmenvy liquid portion only administration). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 5-DEC-2025 A healthcare provider wanted to know how to proceed with a patient that received only the liquid portion of Penmenvy. She was not sure if it was given on 21-NOV-2025 or 26-NOV-2025 and also did not know patient's details. The vaccine administration facility was the same as primary reporter.